|
| | HR0704 | | LRB102 26534 LAW 37130 r |
|
|
| 1 | | HOUSE RESOLUTION
|
| 2 | | WHEREAS, March is recognized as National Kidney Month, an |
| 3 | | important opportunity to raise public awareness and |
| 4 | | understanding of rare kidney diseases, such as Apolipoprotein |
| 5 | | L1 (APOL1) mediated kidney disease; and
|
| 6 | | WHEREAS, APOL1 genetic variants account for much of the |
| 7 | | excess risk of chronic and end stage kidney disease for |
| 8 | | persons of African ancestry, including people who identify as |
| 9 | | African American, Afro Caribbean, and Latinx; and
|
| 10 | | WHEREAS, APOL1 explains the disproportionate rate of |
| 11 | | kidney disease in people of African ancestry; African |
| 12 | | Americans make up 13% of the U.S. population but account for |
| 13 | | 32% of all kidney failure and 35% of all end stage kidney |
| 14 | | disease; in addition, African Americans are four times more |
| 15 | | likely to develop kidney failure than white Americans; and
|
| 16 | | WHEREAS, APOL1 mediated kidney disease is driven by |
| 17 | | genetic factors and is underdiagnosed; and
|
| 18 | | WHEREAS, APOL1 symptoms do not present until kidney damage |
| 19 | | is advanced; symptoms include fatigue, swelling in the legs |
| 20 | | and feet, and weight gain, among others; and
|